NCT05393531View on ClinicalTrials.gov

First Line Obstructive Sleep Apnea Treatment Study

PHASE4CompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

November 9, 2021

Primary Completion Date

January 25, 2024

Study Completion Date

June 30, 2024

Conditions
Obstructive Sleep Apnea
Interventions
DEVICE

Mandibular advancement device (MAD)

Active therapy

DEVICE

Continuous positive airway pressure (CPAP)

Active therapy

Trial Locations (1)

2650

Antwerp University Hospital, Edegem

All Listed Sponsors
lead

University Hospital, Antwerp

OTHER

NCT05393531 - First Line Obstructive Sleep Apnea Treatment Study | Biotech Hunter | Biotech Hunter